Haupt Pharma Amareg GmbH
Business Strategies
Haupt Pharma Amareg GmbH, with its 400 employees, is part of the global Aenova Group. The Aenova Group is global leader in the pharmaceutical and healthcare industries. Competence and experience are the key factors for our success. With an emphasis on innovative technologies and high quality standards, we are a reliable partner for the pharmaceutical and healthcare industry. Aenova is one of the leading contract manufacturers in Europe (CDMO).
Haupt Pharma Amareg produces and packs almost all dosage forms such as solid forms (tablets, film-coated tablets, capsules) as well as semi-solid forms (such as creams), and also liquid forms (e.g. nasal spray) at the Regensburg site. A focus is mainly on the production of hormones and cytostatics, which are produced in separate areas under full protection.
We are proud of the expansion of the development department in Regensburg, which is performing pharmaceutical developments for more than 25 customers. In the formulation development, new formulations and manufacturing processes are developed in small batch sizes for new active ingredients and pharmaceuticals that are not available on the market in this form yet. At the same time, colleagues in the in-house laboratory develop the appropriate analytical testing methods. After the successful formulation development and drug approval the aim is to carry out routine production for customers.
High standards of quality, innovative technologies, and a clear focus on the future ensure the continuing success and dynamic growth of the Group. We make long-term investments in the development of new products and the improvement of our production processes. At the same time, we are able to flexibly and rapidly react to changing requirements from customers and markets. Thanks to this strategy, Aenova ensures its long-term competitiveness and continuously increases its market share.
The Group operates 22 sites in eight European countries, Asia and the USA. 10 of our sites and our company headquarters are located in Germany. More than 4,300 employees contribute to our success.
Core Technologies and Services
Area of expertise: Powder technology (cytostatics, immunosuppressants, hormones, other), semi-solid and liquid dosage forms, packaging
Patents, Licenses, Co-operations
Haupt Pharma Amareg is part of the Aenova Group.
